Neurotech Pharmaceuticals, Inc.
Julie Poirot Williams has an extensive background in clinical operations within the pharmaceutical industry. Julie has held various roles such as Director of Clinical Operations at Neurotech Pharmaceuticals, Inc., Lead CRA at ProTrials Research Inc., Project Lead at inVentiv Health Clinical, and Lead CRA at MedTrials, Inc. With a Master of Science in Integrative Biomedical Sciences specializing in Molecular Biology and Clinical Research Management from UNT Health Science Center, Julie also holds a Bachelor of Science in Biology from Midwestern State University.
This person is not in any offices
Neurotech Pharmaceuticals, Inc.
Neurotech Pharmaceuticals, Inc. is a privately held biotech company located in Cumberland, Rhode Island. Neurotech has spent years developing the science, technology, team and manufacturing behind NT-501. As a result of a unique partnership and clear direction, we are focused on bringing a long-term treatment to Macular Telangiectasia (MacTel) patients. Our team is focused on bringing to market this treatment designed to slow the progression of MacTel and the vision impairments it causes in patients who don't have another treatment option. Our goal is to help these patients sustain their quality of life.